Hospital
Ely-Bloomenson Community Hospital
Ely-Bloomenson Community Hospital was paid $228K by Medicaid between Feb 2018 and Jul 2024, across 12 billing codes. Its largest line is 99283, emergency room visit (moderate) — 59% of everything it billed.
33Billing provider infoELY-BLOOMENSON COMMUNITY HOSPITAL
ELY, MN 55731
ELY, MN 55731
33aNPI1770542904assigned 03/17/2006
33bProvider typeCritical Access Hospital
28Total paid$228K
24GClaims2,989
24DCodes billed12
24AFirst – last monthFeb 2018 – Jul 2024
Compared with peers
Next to other Critical Access Hospital providers in Minnesota
Rank by total paid#50 of 68
Median peer was paid$798K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 144 | $4K | |
| 2019 | 342 | $22K | |
| 2020 | 433 | $29K | |
| 2021 | 748 | $39K | |
| 2022 | 531 | $55K | |
| 2023 | 589 | $63K | |
| 2024incomplete | 202 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 59% | 1,063 | 795 | $135K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 188 | 113 | $34K |
| 80053 | Comprehensive metabolic panel | 6.6% | 166 | 155 | $15K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.9% | 320 | 273 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.9% | 195 | 148 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 260 | 241 | $8K |
| J3490 | Unclassified drugs | 2.4% | 422 | 186 | $5K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 248 | 222 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 17 | 15 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 39 | 37 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 56 | 12 | $1K |
| 83735 | <1% | 15 | 12 | $527.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBANKS, PATRICIA (CEO)